1. Home
  2. AAPG vs CXM Comparison

AAPG vs CXM Comparison

Compare AAPG & CXM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AAPG
  • CXM
  • Stock Information
  • Founded
  • AAPG 2009
  • CXM 2009
  • Country
  • AAPG China
  • CXM United States
  • Employees
  • AAPG N/A
  • CXM N/A
  • Industry
  • AAPG Biotechnology: Pharmaceutical Preparations
  • CXM Computer Software: Prepackaged Software
  • Sector
  • AAPG Health Care
  • CXM Technology
  • Exchange
  • AAPG Nasdaq
  • CXM Nasdaq
  • Market Cap
  • AAPG 2.2B
  • CXM 2.2B
  • IPO Year
  • AAPG 2025
  • CXM 2021
  • Fundamental
  • Price
  • AAPG $24.40
  • CXM $8.43
  • Analyst Decision
  • AAPG Buy
  • CXM Hold
  • Analyst Count
  • AAPG 1
  • CXM 14
  • Target Price
  • AAPG N/A
  • CXM $9.79
  • AVG Volume (30 Days)
  • AAPG 14.1K
  • CXM 1.0M
  • Earning Date
  • AAPG 06-10-2025
  • CXM 06-04-2025
  • Dividend Yield
  • AAPG N/A
  • CXM N/A
  • EPS Growth
  • AAPG N/A
  • CXM 144.44
  • EPS
  • AAPG N/A
  • CXM 0.44
  • Revenue
  • AAPG $134,352,180.00
  • CXM $796,394,000.00
  • Revenue This Year
  • AAPG N/A
  • CXM $4.24
  • Revenue Next Year
  • AAPG $389.09
  • CXM $5.47
  • P/E Ratio
  • AAPG N/A
  • CXM $19.18
  • Revenue Growth
  • AAPG 341.77
  • CXM 8.74
  • 52 Week Low
  • AAPG $16.50
  • CXM $6.75
  • 52 Week High
  • AAPG $26.55
  • CXM $11.79
  • Technical
  • Relative Strength Index (RSI)
  • AAPG N/A
  • CXM 58.80
  • Support Level
  • AAPG N/A
  • CXM $7.97
  • Resistance Level
  • AAPG N/A
  • CXM $8.55
  • Average True Range (ATR)
  • AAPG 0.00
  • CXM 0.18
  • MACD
  • AAPG 0.00
  • CXM 0.02
  • Stochastic Oscillator
  • AAPG 0.00
  • CXM 74.80

About AAPG Ascentage Pharma Group International American Depository Shares

Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies. The company's geographical segments include the United States and Mainland China.

About CXM Sprinklr Inc.

Sprinklr Inc is engaged in enabling customer-facing teams, from Customer Service to Marketing, to collaborate across internal silos, communicate across digital channels, and leverage AI to deliver customer experiences at scale all on one unified AI-based platform. It focuses on empowering companies to deliver next-generation, unified engagement journeys that reimagine the customer's experience. Its products include Sprinklr Service, Sprinklr Social, Sprinklr Insights and Sprinklr Marketing. The company operates in the Americas, EMEA, and other countries. It derives maximum revenue from the Americas.

Share on Social Networks: